Quadrivalent seasonal influenza vaccine GSK2282512A

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Influenza

Phase 3

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults

CompletedNCT01196975

GlaxoSmithKlineInfluenza

Start: 2010-10-01End: 2011-06-24Updated: 2018-09-21

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children

CompletedNCT01198756

GlaxoSmithKlineInfluenza

Start: 2010-10-01End: 2011-07-01Updated: 2018-09-21

Related Papers

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.

2014-01-2864 citations

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

The Journal of Infectious Diseases2013-07-1166 citations